Buy 2 and save 29.21 USD / -16%
Cimifemin uno contains a dry extract of Cimicifuga rootstock (Cimicifuga racemosa (L.) Nutt., rhizoma).
Cimifemin uno is used for symptoms associated with menopause (hot flashes, sweating, sleep disorders, nervousness and mood disorders). These can be alleviated by Cimifemin uno.
Swissmedic-approved patient information
Cimifemin® uno tabletsZeller Medical AGHerbal medicinal product
Cimifemin uno contains a dry extract of Cimicifuga rootstock (Cimicifuga racemosa (L.) Nutt. , rhizoma).
Cimifemin uno is used for symptoms associated with menopause (hot flashes, sweating, sleep disorders, nervousness and mood disorders). These can be alleviated by Cimifemin uno.
In the event of an unusual drop in performance, yellowing of the eyes or skin, dark urine or discolored stools, Cimifemin uno should be discontinued and a doctor or to see a doctor.
If you have a feeling of tension or swelling in the breasts, or if you experience bleeding between periods, spotting or recurring menstrual bleeding, you should consult your doctor.
This medicinal product contains 44 mg of digestible carbohydrate per tablet. The drug is suitable for diabetics.
Cimifemin uno should not be used if there is a known hypersensitivity to one of the ingredients or to ranunculaceae (buttercup family). . In the case of pre-existing liver damage, it is not recommended to take Cimifemin uno. This preparation influences the physical and psychological symptoms of menopause (climacteric). Since there are no clinical data that show a beneficial effect on bones, this preparation cannot be used to prevent osteoporosis.
Cimifemin uno contains lactose. Please only take Cimifemin uno after consulting your doctor if you know that you suffer from sugar intolerance.
This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, i.e. essentially 'sodium-free'. it is almost «sodium-free».
Tell your doctor, pharmacist or druggist if you:
Cimifemin uno is indicated for women going through the menopause. Use during pregnancy and lactation is not intended. As a precaution, you should avoid taking medicines during pregnancy and breastfeeding or ask your doctor, pharmacist or druggist for advice.
Adults: Unless otherwise prescribed, take 1 tablet whole once a day with some liquid. Cimifemin uno can be used for a longer period of time, at least for a period of 6 weeks. Use for more than 6 months should only take place after consultation with your doctor.
The use and safety of Cimifemin uno in children and adolescents has not yet been tested.
Follow the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.
The following side effects can occur when taking Cimifemin uno:
If you notice any side effects, contact us Contact your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.
The medicinal product may only be used up to the date marked «EXP» on the container.
Store at room temperature (15-25°C) in the original packaging.
Keep out of the reach of children.
Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.
Extract particles may be visible on the surface of the tablets in the form of small brown dots and are harmless.
One tablet contains 6.5 mg dry extract of Cimicifuga rhizome (Cimicifuga racemosa (L.) Nutt., rhizoma), drug extract -Ratio 4.5 – 8.5:1, extractant: 60% ethanol (V/V).
Lactose monohydrate (44 mg), croscarmellose sodium (corresponds to a maximum of 0.65 mg sodium), microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, povidone.
56933 (Swissmedic)
In pharmacies and drugstores, without a doctor's prescription.
Blisters of 30 and 90 tablets.
Zeller Medical AG, CH-8590 Romanshorn
This leaflet was last checked by the Medicines Agency (Swissmedic) in October 2020.